We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

247 hedge funds and large institutions have $3.4B invested in Arena Pharmaceuticals Inc in 2020 Q2 according to their latest regulatory filings, with 59 funds opening new positions, 82 increasing their positions, 74 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 3 → 9 (+6)

118% more call options, than puts

Call options by funds: $44.6M | Put options by funds: $20.4M

97% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 30

76% more capital invested

Capital invested by funds: $1.93B → $3.4B (+$1.47B)

13% more funds holding

Funds holding: 219 → 247 (+28)

11% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 74

Holders
247
Holders Change
+28
Holders Change %
+12.79%
% of All Funds
5.06%
Holding in Top 10
9
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+200%
% of All Funds
0.18%
New
59
Increased
82
Reduced
74
Closed
30
Calls
$44.6M
Puts
$20.4M
Net Calls
+$24.1M
Net Calls Change
+$17M

Top Buyers

Rank Fund Capital Flow
1
Alkeon Capital Management
Alkeon Capital Management
New York
+$54.5M
2
ACA
Avoro Capital Advisors
New York
+$52.3M
3
GPP
Great Point Partners
Connecticut
+$50.3M
4
FCM
Farallon Capital Management
California
+$49.5M
5
MWNA
Marshall Wace North America
New York
+$47.5M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$47M
2
PHS
PFM Health Sciences
California
-$26.8M
3
Holocene Advisors
Holocene Advisors
New York
-$24.4M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$22.3M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$19.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Commonwealth Equity Services
151
Commonwealth Equity Services
Massachusetts
$580K +$90.8K +1,650 +22%
Canada Life
152
Canada Life
Manitoba, Canada
$536K +$288K +5,240 +158%
TRCT
153
Tower Research Capital (TRC)
New York
$533K +$466K +8,464 New
WMSA
154
Weiss Multi-Strategy Advisers
New York
$505K +$441K +8,019 New
Public Employees Retirement Association of Colorado
155
Public Employees Retirement Association of Colorado
Colorado
$499K – – –
SAM
156
Shell Asset Management
Netherlands
$496K -$3.58K -65 -0.8%
BP
157
Ballentine Partners
Massachusetts
$472K -$1.26K -23 -0.3%
Bank Julius Baer & Co
158
Bank Julius Baer & Co
Switzerland
$457K +$399K +7,253 New
PAG
159
Private Advisory Group
Washington
$450K +$393K +7,146 New
Bank of Montreal
160
Bank of Montreal
Ontario, Canada
$440K +$265K +4,808 +256%
FC
161
FORA Capital
Florida
$403K +$352K +6,398 New
PP
162
Paloma Partners
Connecticut
$394K +$345K +6,264 New
Zurich Cantonal Bank
163
Zurich Cantonal Bank
Switzerland
$384K +$123K +2,239 +58%
DIM
164
DC Investments Management
Virginia
$375K +$328K +5,956 New
DT
165
Diversified Trust
Tennessee
$372K +$325K +5,904 New
LPL Financial
166
LPL Financial
California
$370K -$26.4K -479 -8%
PC
167
Polar Capital
United Kingdom
$366K -$254K -4,622 -44%
VEA
168
Virtus ETF Advisers
New York
$359K -$107K -1,943 -25%
Stifel Financial
169
Stifel Financial
Missouri
$359K +$314K +5,703 New
CF
170
CNA Financial
Illinois
$348K +$304K +5,521 New
Wolverine Trading
171
Wolverine Trading
Illinois
$330K +$289K +5,260 New
AB
172
Amalgamated Bank
New York
$327K -$197K -3,586 -41%
EGM
173
Engineers Gate Manager
New York
$325K -$126K -2,286 -31%
IC
174
Ikarian Capital
Texas
$315K +$275K +5,000 New
AIP
175
Ameritas Investment Partners
Nebraska
$309K +$20.9K +380 +8%
5 6
7
8 9

ARNA Hedge Fund Activity: Q2 2020 in Review

247 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2020, worth a combined $3.4B — up 76% from $1.93B a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new ARNA positions and 30 closed out — a net gain of 29 holders — while 82 added to existing stakes and 74 trimmed.

The largest buyer was Alkeon Capital Management, adding an estimated $54.5M. The largest seller was Victory Capital Management, cutting an estimated $47M.

  • 247 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2020, up from 219 in Q1 2020.
  • Funds reported $3.4B of Arena Pharmaceuticals Inc stock for Q2 2020, up 76% quarter-over-quarter.
  • 59 funds opened new Arena Pharmaceuticals Inc positions in Q2 2020 and 30 closed out, a net change of +29 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2020 was Alkeon Capital Management, an estimated $54.5M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2020 was Victory Capital Management, an estimated $47M sold.

Based on aggregated 13F filings for Q2 2020.